Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

1995283 citationsJournal Article

Authors

N. M. Bleehen · Addenbrooke's Hospital

E.S. Newlands

Abstract

Temozolomide in the schedule used has as good activity in chemotherapy-naive metastatic melanoma as the other most active agents currently in use. Further studies of the drug on its own and in combination with other agents is recommended.

Topics & Keywords

Melanoma and MAPK Pathways Photodynamic Therapy Research Studies Nanoplatforms for cancer theranostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 13, Issue 4, pp. 910-913

DOI: 10.1200/jco.1995.13.4.910

Field-Weighted Citation Impact: 3.52